Vertebrate UDP-glucuronosyltransferases: Functional and evolutionary aspects

Biochemical Pharmacology

Volumn 66, Issue 5, 2003, Pages 691-696

  Bock, Karl Walter ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Co regulation of CYPs and UGTs; Drug metabolizing enzymes; Gastrointestinal barrier; UDP glycosyltransferase superfamily; Vertebrate UDP glucuronosyltransferases

Indexed keywords

ANTHOCYANIN; CHRYSIN; DRUG METABOLIZING ENZYME; GLUCURONOSYLTRANSFERASE; QUERCETIN; RESVERATROL; TATA BINDING PROTEIN; ZEAXANTHIN;

BIOTRANSFORMATION; DRUG DETOXIFICATION; DRUG ELIMINATION; DRUG METABOLISM; GENE LOCUS; GENETIC POLYMORPHISM; MULTIGENE FAMILY; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW;

EID: 0041930641     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00296-X     Document Type: Note

References (61)

1. König J., Nies A.T., Cui Y., Leier I., Keppler D. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP-mediated drug resistance. Biochim. Biophys. Acta. 1461:1999;377-394.
2. Mackenzie P.I., Owens I.S., Burchell B., Bock K.W., Bairoch A., Belanger S., Fournel-Gigleux S., Green M., Hum D.W., Iyanagi T., Lancet D., Louisot P., Magdalou J., Roy Chowdhury J., Ritter J.K., Schachter H., Tephly T.R., Tipton K.F., Nebert D.W. The UDP-glucuronosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics. 7:1997;255-269.
3. UGT home page (http://som.flinders.edu.au/FUSA/ClinPharm/UGT).
4. Ando Y., Saka A., Asai G., Sugiura S., Shimokata K., Kamataki T. UGT1A1 genotypes and glucuronidation of SN38, the active metabolite of irinotecan. Ann. Oncol. 9:1998;845-847.
5. Zheng Z., Park J.Y., Guillemette C., Schantz S.P., Lazarus P. Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with cancer risk. J. Natl. Cancer Inst. 93:2001;1411-1418.
6. Galijatovic A., Walle U.K., Walle T. Induction of UDP-glucuronosyltransferase by flavonoids chrysin and quercetin in Caco-2 cells. Pharm. Res. 17:2000;21-26.
7. Ford C.M., Boss P.K., Hoj P.B. Cloning and characterization of Vitis vinifera UDP-glucose: flavonoid 3-O-glucosyltransferase, a homologue of the enzyme encoded by the maize Bronze-1 locus that may primarily serve to glucosylate anthocyanidins in vivo. J. Biol. Chem. 273:1998;9224-9233.
8. Gehm B.D., McAndrews J.M., Chien P.-Y., Jameson J.L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 94:1997;14138-14143.
9. Hundle B.S., O'Brien D.A., Alberti M., Beyer P., Hearst J.E. Functional expression of zeaxanthin glucosyltransferase from Erwinia herbicola and a proposed uridine diphosphate binding site. Proc. Natl. Acad. Sci. U.S.A. 89:1992;9321-9325.
10. Tukey R.H., Strassburg C.P. Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract. Mol. Pharmacol. 59:2001;405-414.
11. Nebert D.W., Petersen D.D., Fornace A.J. Cellular responses to oxidative stress: the Ah gene battery as a paradigm. Environ. Health Perspect. 88:1990;13-25.
12. Raijmakers M.T., Jansen P.L., Steegers E.A., Peters W.H. Association of human liver bilirubin UDP-glucuronosyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene. J. Hepatol. 33:2000;348-351.
13. Save J., Kager L., Svensson Eng J.O., Rane A. Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation. Br. J. Clin. Pharmacol. 19:1985;495-501.
14. Sun X.Y., Plouzek C.A., Henry J.P., Wang T.T.Y., Phang J.M. Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by Biochanin A in prostate cancer cells. Cancer Res. 58:1998;2379-2384.
15. Mistry M., Houston J.B. Glucuronidation in vitro and in vivo. Comparison of intestinal and hepatic conjugation of morphine, naloxone and buprenorphine. Drug Metab. Dispos. 15:1987;710-717.
16. Soars M.G., Burchell B., Riley R.J. In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance. J. Pharmacol. Exp. Ther. 301:2002;382-390.
17. Bosma P.J., Roy Choudhury J., Bakker C., Gantla S., de Boer A., Oostra B.A., Lindout D., Tytgat G.N., Jansen P.L., Oude Elferink R.P., Roy Chowdhury N. The genetic basis of the reduced expression of bilirubin UDP glucuronosyltransferase 1 in Gilbert's syndrome. New Engl. J. Med. 333:1995;1171-1175.
18. Monogan G., Ryan M., Seddon R., Hume R., Burchell B. Genetic variation in bilirubin UDP glucuronosyltransferase promoter and Gilbert's syndrome. Lancet. 347:1996;578-581.
19. Ando Y., Saka H., Ando M., Sawa T., Muro K., Ueoka H., Yokoyama A., Saitoh S., Shimokawa K., Hasegawa Y. Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res. 60:2000;6921-6926.
20. Beutler E., Gelbart T., Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc. Natl. Acad. Sci. U.S.A. 95:1998;8170-8174.
21. Hall D., Ybazeta G., Destro-Bisol G., Petzl-Erler M.L., DiRienzo A. Variability at the uridine diphosphate glucuronosyltransferase 1A1 promoter in human populations and primates. Pharmacogenetics. 9:1999;591-599.
22. Baranano D.E., Rao M., Ferris C.D., Snyder S.H. Biliverdin reductase: a major physiologic cytoprotectant. Proc. Natl. Acad. Sci. U.S.A. 99:2002;16093-16098.
23. Vitek L., Jirsa M., Brodonova M., Kalab M., Marecek Z., Danzig V., Novotny L., Kotal P. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Artheriosclerosis. 160:2002;449-456.
24. *3) in Caucasians and Egyptians. Biochem Pharmacol 2003;65:1521-7.
25. Gillemette C., Ritter J.K., Auyeung D.J., Kessler F.K., Housman D.E. Structural heterogeneity of the UDP-glucuronosyltransferase 1 locus: functional consequences of three missense mutations in the UGT1A7 gene. Pharmacogenetics. 10:2000;629-644.
26. Strickberger MW. Evolution. Jones and Barlett; 2000. p. 93.
27. Li Q., Lamb G., Tukey R.H. Characterization of the UDP-glucuronosyltransferase 1A locus in lagomorphs: evidence for duplication of the UGT1A6 gene. Mol. Pharmacol. 58:2000;89-97.
28. Court M.H., Greenblatt D.J. Molecular genetic analysis for deficient acetaminophen glucuronidation in cats: UGT1A6 is a pseudogene, and evidence for reduced diversity of expressed hepatic UGT isoforms. Pharmacogenetics. 10:2000;355-369.
29. Clarke D.J., Burchell B., George S.G. Differential expression and induction of UDP-glucuronosyltransferase isoforms in hepatic and extrahepatic tissues of a fish, Pleuronectes platessa: immunochemical and functional characterization. Toxicol. Appl. Pharmacol. 115:1992;130-136.
30. Clarke D.J., George S.G., Burchell B. Multiplicity of UDP-glucuronosyltransferase in fish. Biochem. J. 284:1992;417-423.
31. Buchmann A., Wannemacher R., Kulzer E., Buhler D.R., Bock K.W. Immunohistochemical localization of the cytochrome P450 isoenzymes LMC2 and LM4B (P4501A1) in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated zebrafish (Brachydanio rerio). Toxicol. Appl. Pharmacol. 123:1993;160-169.
32. George S.G., Taylor B. Molecular evidence for multiple UDP-glucuronosyltransferase families in fish. Mar. Environ. Res. 54:2002;253-257.
33. Dutton GJ. Glucuronidation of drugs and other compounds. Boca Raton: CRC Press; 1980. p. 126.
34. Inscoe J.K., Axelrod J. Some factors affecting glucuronide formation in vitro. J. Pharmacol. Exp. Ther. 129:1960;128-131.
35. Bock K.W., Fröhling W., Remmer H., Rexer B. Effects of phenobarbital and 3-methylcholanthrene on substrate specificity of rat liver microsomal UDP-glucuronyltransferase. Biochim. Biophys. Acta. 327:1973;46-56.
36. Owens I.S. Genetic regulation of UDP-glucuronosyltransferase induction by polycyclic aromatic compounds in mice. J. Biol. Chem. 252:1977;2827-2833.
37. Watkins J.B., Gregus Z., Thompson T.N., Klaasen C.D. Induction studies of rat liver UDP-glucuronosyltransferases. Toxicol. Appl. Pharmacol. 64:1982;439-446.
38. Xie W., Yeuh M.F., Radominska-Pandya A., Saini S.P.S., Negishi Y., Botroff B.S., Cabrera G.Y., Tukey R.H., Evans R.M. Control of steroid, heme and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc. Natl. Acad. Sci. U.S.A. 100:2003;4150-4155.
39. Emi Y., Ikushiro S., Iyanagi T. Xenobiotic responsive element-mediated transcriptional activation in the UDP-glucuronosyltransferase family 1 gene complex. J. Biol. Chem. 271:1996;3952-3958.
40. Münzel P.A., Lehmköster T., Brück M., Ritter J.K., Bock K.W. Aryl hydrocarbon receptor-inducible or constitutive expression of human UDP glucuronosyltransferase UGT1A6. Arch. Biochem. Biophys. 350:1998;72-78.
41. Bock K.W., Lipp H.P., Bock-Hennig B.S. Induction of drug-metabolizing enzymes by xenobiotics. Xenobiotica. 20:1990;1101-1111.
42. Auyeung D.J., Kessler F.K., Ritter J.K. An alternative promoter contributes to tissue- and inducer-specific expression of the rat UDP-glucuronosyltransferase 1A6 gene. Toxicol. Appl. Pharmacol. 174:2001;60-68.
43. Prochaska H.J., Talalay P. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res. 48:1988;4776-4782.
44. Ramos-Gomez M., Kwak M.K., Dolan P.M., Itoh K., Yamamoto M., Talalay P., Kensler T.W. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 98:2001;3410-3415.
45. Bock K.W., Eckle T., Ouzzine M., Fournel-Gigleux S. Coordinate induction by antioxidants of UDP-glucuronosyltransferase UGT1A6 and the apical conjugate export pump MRP2 (multidrug resistance protein 2) in Caco-2 cells. Biochem. Pharmacol. 59:2000;467-470.
46. Johnson D.R., Klaasen C.D. Regulation of rat multidrug resistance protein 2 by classes of prototypical microsomal enzyme inducers that activate distinct transcription pathways. Toxicol. Sci. 67:2002;182-189.
47. Senafi S.B., Clarke D.J., Burchell B. Investigation of the substrate specificity of a cloned expressed human liver UDP-glucuronosyltransferase:UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem. J. 303:1994;233-240.
48. Gschaidmeier H., Seidel A., Burchell B., Bock K.W. Formation of mono- and diglucuronides and other glycosides of benzo(a)pyrene-3,6-quinol by V79-expressed human phenol UDP-glucuronosyltransferases of the UGT1 gene complex. Biochem. Pharmacol. 49:1995;1601-1606.
49. Mackenzie P., Little J.M., Radominska-Pandya A. Glucosidation of hyodeoxycholic acid by UDP-glucuronosyltransferase 2B7. Biochem. Pharmacol. 65:2003;417-421.
50. Tang C., Hochman J.H., Ma B., Subramanian R., Vyas K.P. Acyl glucuronidation and glucosidation of a new and selective endothelin ETA receptor antagonist in human liver microsomes. Drug Metab. Dispos. 31:2003;37-45.
51. Morello A., Repetto Y. UDP-glucosyltransferase activity of housefly microsomal fraction. Biochem. J. 177:1979;809-812.
52. Luque T., Okano K., O'Reilly D.R. Characterization of a novel silkworm (Bombyx mori) phenol UDP-glucosyltransferase. Eur. J. Biochem. 269:2002;819-825.
53. Wang Q., Hasan G., Pikielny C.W. Preferential expression of biotransformation enzymes in the olfactory organs of Drosophila melanogaster, the antennae. J. Biol. Chem. 274:1999;10309-10315.
54. O'Reilly D.R., Miller L.K. A baculovirus blocks insect molting by producing ecdysteroid UDP-glucose transferase. Science. 245:1989;1110-1112.
55. Evans O.P., O'Reilly D.R. Purification and kinetic analysis of a baculovirus ecdysteroid UDP-glucosyltransferase. Biochem. J. 330:1998;1265-1270.
56. Ritter J.K., Chen F., Sheen Y.Y., Tran H.M., Kimura S., Yearman M.T., Owens I.S. A novel complex locus UGT1 encodes human bilirubin, phenol and other UDP-glucuronosyltransferase isozymes with identical carbonyl termini. J. Biol. Chem. 267:1992;3257-3261.
57. Gong G.H., Cho J.W., Potter C., Gholomi N., Basu N.K., Kubota S., Carvalho S., Pennington M.W., Owens I.S., Popescu N.C. Thirteen UDPglucuronosyltransferase genes are encoded at the human UDP1 gene complex locus. Pharmacogenetics. 11:2001;357-368.
58. Münzel P.A., Schmohl S., Heel H., Kälberer K., Bock-Hennig B.S., Bock K.W. Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT 2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells. Drug Metab. Dispos. 27:1999;569-573.
59. Ritter J.K., Kessler F.K., Thompson M.T., Grove A.D., Auyeung D.J., Fisher R.A. Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: evidence for both genetic and environmental influences. Hepatology. 30:1999;476-484.
60. Yueh M.F., Huang Y.A., Chen S., Nguyen N., Tukey R.H. Involvement of the xenobiotic response element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1. J. Biol. Chem. 278:2003;15001-15006.
61. Iyanagi T. Molecular basis of multiple UDP-glucuronosyltransferase isoenzyme deficiencies in the hyperbilirubinemic rat (Gunn rat). J. Biol. Chem. 266:1991;24048-24052.